Whirly lollipop on orange background.

We were initially pretty excited about Revance (RVNC) based on our work in and around the theme we refer to as "aging population." The lead product at Revance is a form of botox that can be applied topically rather than injected.

The story is still a good one but when we went through the transcript of the IPO roadshow more carefully a couple of things stuck in our craw. Specifically:

Want the rest of the article?

Please login or join us as a member to view our complete content!